COVID-19 treatment | Natco Pharma seeks approval to launch phase-3 trial of Molnupiravir

Natco said it is hoping that CDSCO would give emergency approval of this drug based on “compassionate use” for patients.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-natco-pharma-seeks-approval-to-launch-phase-3-trialmolnupiravir_15035401.html